iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) Stock Holdings Trimmed by Moloney Securities Asset Management LLC

Moloney Securities Asset Management LLC lowered its holdings in shares of iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 5.8% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,989 shares of the financial services provider’s stock after selling 123 shares during the period. Moloney Securities Asset Management LLC’s holdings in iShares Nasdaq Biotechnology ETF were worth $217,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in IBB. Optimum Investment Advisors grew its holdings in shares of iShares Nasdaq Biotechnology ETF by 5.1% in the 2nd quarter. Optimum Investment Advisors now owns 3,794 shares of the financial services provider’s stock worth $414,000 after acquiring an additional 184 shares during the last quarter. LeJeune Puetz Investment Counsel LLC acquired a new position in shares of iShares Nasdaq Biotechnology ETF in the 2nd quarter worth $107,000. SG Americas Securities LLC acquired a new position in shares of iShares Nasdaq Biotechnology ETF in the 2nd quarter worth $16,695,000. Psagot Investment House Ltd. grew its holdings in shares of iShares Nasdaq Biotechnology ETF by 6.0% in the 2nd quarter. Psagot Investment House Ltd. now owns 9,500 shares of the financial services provider’s stock worth $1,036,000 after acquiring an additional 538 shares during the last quarter. Finally, Osborn Williams & Donohoe LLC grew its holdings in shares of iShares Nasdaq Biotechnology ETF by 23.6% in the 2nd quarter. Osborn Williams & Donohoe LLC now owns 31,404 shares of the financial services provider’s stock worth $3,426,000 after acquiring an additional 6,006 shares during the last quarter. 73.00% of the stock is currently owned by hedge funds and other institutional investors.

Shares of NASDAQ IBB traded down $0.40 during mid-day trading on Friday, reaching $105.48. The company had a trading volume of 2,244,794 shares, compared to its average volume of 2,240,026. The business has a 50-day moving average price of $106.65. iShares Nasdaq Biotechnology ETF has a 1-year low of $89.01 and a 1-year high of $122.97.

About iShares Nasdaq Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Featured Story: Understanding the two types of arbitrage

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB).

Institutional Ownership by Quarter for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.